Matteo Lambertini, MD PhD(@matteolambe) 's Twitter Profile Photo

The calculator to help predicting the risk of late distant recurrence in postmenopausal patients with -positive early is freely available online: future possible application also in -positive and premenopausal settings?

The #CTS5 calculator to help predicting the risk of late distant recurrence in postmenopausal patients with #EstrogenReceptor-positive early #BreastCancer is freely available online: future possible application also in #HER2-positive and premenopausal settings? #SABCS18
account_circle
OurMBCLife(@ourmbclife) 's Twitter Profile Photo

In this podcast, Dr. Virginia Kaklamani discusses ESR1 mutations, treatments and some developments in research for HR+ MBC.
🎧 Listen (all channels) or 🔗 buff.ly/3GLib7y

In this podcast, Dr. Virginia Kaklamani discusses ESR1 mutations, treatments and some developments in research for HR+ MBC.
🎧  Listen (all channels) or 🔗 buff.ly/3GLib7y
#ESR1 #SERDS #EstrogenReceptor
account_circle
Matteo Lambertini, MD PhD(@matteolambe) 's Twitter Profile Photo

Two papers in nature this week with these important messages: 1) do not abuse of ; 2) genomic analysis may help improving the prediction of late recurrences in patients with -positive or tumors

Two #BreastCancer papers in @nature this week with these important messages: 1) do not abuse of #glucocorticoids; 2) genomic analysis may help improving the prediction of late recurrences in patients with #EstrogenReceptor-positive or #TreipleNegative tumors
#bcsm #OncoAlert
account_circle
Molecular Oncology(@MolOncology) 's Twitter Profile Photo

📢Hot off the press!

The TRAR gene classifier to predict response to neoadjuvant therapy in HER2+ and ER+ breast cancer patients: an explorative analysis from the NeoSphere trial

🔗buff.ly/3e5YHfq

Tiziana Triulzi Ospedale San Raffaele

📢Hot off the press!

The TRAR gene classifier to predict response to neoadjuvant therapy in HER2+ and ER+ breast cancer patients: an explorative analysis from the NeoSphere trial

🔗buff.ly/3e5YHfq

@TizianaTriulzi @SanRaffaeleMI

#HER2 #BreastCancer #EstrogenReceptor
account_circle
Molecular Oncology(@MolOncology) 's Twitter Profile Photo

💫Codon adaptation by synonymous mutations impacts the functional properties of the estrogen receptor-alpha protein in breast cancer cells

🔗buff.ly/43zddUq

💫Codon adaptation by synonymous mutations impacts the functional properties of the estrogen receptor-alpha protein in breast cancer cells

🔗buff.ly/43zddUq

#EvolBio #CancerResearch #EvoDevo #CancerEvolution #EstrogenReceptor
account_circle
NCI Systems Biology(@NCIsysbio) 's Twitter Profile Photo

Dr. Russell Rockne (Russell Rockne) et al. City of Hope are using an integrated experimental–computational approach to unravel the complexity of immune signaling networks in positive . csbconsortium.org/research-proje…

Dr. Russell Rockne (@rrockne) et al. @cityofhope #NCICSBC are using an integrated experimental–computational approach to unravel the complexity of immune signaling networks in #estrogenreceptor positive #breastcancer. csbconsortium.org/research-proje… #CIM22 #Immune2Cancer
account_circle
Clinical Cancer Research(@CCR_AACR) 's Twitter Profile Photo

Oral selective antagonist and degrader is well tolerated and potentially clinically active as a single agent and in combination with Palbociclib in patients with ER+ . bit.ly/41sk2HX
Komal Jhaveri

Oral selective #EstrogenReceptor antagonist and degrader #giredestrant is well tolerated and potentially clinically active as a single agent and in combination with Palbociclib in patients with ER+ #BreastCancer. bit.ly/41sk2HX
@jhaveri_komal
account_circle